Clinical trial looks at tramadol for opioid withdrawal

July 12, 2017, The JAMA Network Journals

A randomized clinical trial published by JAMA Psychiatry compared tramadol extended-release with clonidine and buprenorphine for the management of opioid withdrawal symptoms in patients with opioid use disorder in a residential research setting.

Opioid use disorder is a public health problem that has contributed to unprecedented levels of overdose deaths. Detoxification - or medically supervised withdrawal - is a widely used treatment for opioid use disorder. However, failing to adequately manage opioid withdrawal symptoms can contribute to people leaving treatment.

Clonidine and buprenorphine are two medications widely used to manage opioid withdrawal. Tramadol hydrochloride is a promising alternative option for effective opioid use disorder treatment, according to the article.

Kelly E. Dunn, Ph.D., of the Johns Hopkins University School of Medicine, Baltimore, and coauthors conducted a in a residential research setting with 103 patients, mostly men, with opioid use disorder. During a seven-day taper, clonidine, buprenorphine or tramadol hydrochloride extended-release, which is an approved analgesic with low abuse potential, were used.

The clinical trial showed tramadol extended-release suppressed withdrawal more than clonidine and was comparable to buprenorphine during a residential tapering program, according to the article.

The study notes some limitations, including a primarily male sample and a lack of specific information regarding past 30-day use of other illicit drugs and alcohol.

"These data suggest that tramadol ER is a promising and valuable medication for the management of opioid withdrawal in patients undergoing treatment for OUD [ use disorder]. Future studies should evaluate whether relapse varies following supervised withdrawal with tramadol ER vs. other medications and whether ER can be used to transition patients to naltrexone ," the article concludes.

Explore further: Injectable therapy blocks opioid euphoria, withdrawal symptoms in trial

More information: JAMA Psychiatry (2017). doi:10.1001/ jamapsychiatry.2017.1838

Related Stories

Injectable therapy blocks opioid euphoria, withdrawal symptoms in trial

June 26, 2017
A study led by investigators in the University of Kentucky Center on Drug and Alcohol Research (CDAR) has demonstrated a weekly injectable formulation of buprenorphine, CAM2038, suppresses symptoms of withdrawal in patients ...

Study examines opioid use in patients with rheumatoid arthritis

June 21, 2017
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly. By 2014, 41% of rheumatoid arthritis patients were regular opioid users.

NIH-led workshop addresses opioid misuse during pregnancy

June 9, 2017
Research is essential to determining how best to screen pregnant women for opioid use disorder, to treat pregnant women who have the disorder, and to care for infants as they experience withdrawal symptoms, according to experts ...

Rural physicians report significant barriers in treating opioid use disorder

July 11, 2017
More than half of rural counties in the United States lack a physician trained and waivered by the Drug Enforcement Agency to treat opioid use disorder using Buprenorphine Maintenance Treatment. Furthermore, many physicians ...

Opioid dependence can start in just a few days

March 16, 2017
(HealthDay)—Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests.

Researchers developing mobile app for opioid detoxification

February 7, 2017
In the midst of the opioid epidemic, an estimated 1.5 million Americans seek treatment annually in an effort to avoid the life-threatening effects of opioid use disorder and improve their quality of life.

Recommended for you

Self-perception and reality seem to line-up when it comes to judging our own personality

December 14, 2018
When it comes to self-assessment, new U of T research suggests that maybe we do have a pretty good handle on our own personalities after all.

Levels of gene-expression-regulating enzyme altered in brains of people with schizophrenia

December 14, 2018
A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) has identified, for the first time, epigenetic differences between the brains of individuals ...

Researchers discover abundant source for neuronal cells

December 13, 2018
USC researchers seeking a way to study genetic activity associated with psychiatric disorders have discovered an abundant source of human cells—the nose.

Video game players frequently exposed to graphic content may see world differently

December 13, 2018
People who frequently play violent video games are more immune to disturbing images than non-players, a UNSW-led study into the phenomenon of emotion-induced blindness has shown.

New genetic clues to early-onset form of dementia

December 13, 2018
Unlike the more common Alzheimer's disease, frontotemporal dementia tends to afflict young people. It accounts for an estimated 20 percent of all cases of early-onset dementia. Patients with the illness typically begin to ...

How teens deal with stress may affect their blood pressure, immune system

December 13, 2018
Most teens get stressed out by their families from time to time, but whether they bottle those emotions up or put a positive spin on things may affect certain processes in the body, including blood pressure and how immune ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Captain Stumpy
1 / 5 (1) Jul 13, 2017
@lying pseudoscience fraud bubba the quack
cures oxycodone addiction
there is absolutely no scientific evidence that supports your assertions in any journal, anywhere

this is called a religious belief

religion often thinks that repeating a lie makes it more true
this may work with cults, but it is not in any way science, nor does it work with people who are capable of seeking valid information to substantiate a claim

considering your attempt to sell your pseudoscience, you must be starting your own cult and are seeking acolytes

enjoy your jail time for fraud
reported

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.